Transposagen Biopharmaceuticals

Company Overview Transposagen, Inc. is a privately-held biotechnology company founded in 2005 to commercialize early gene editing technology for the construction of rodent models of disease. Since then, Transposagen has significantly increased its scientific offerings to include a suite of gene editing technologies and services that address the research needs of both academic and drug discovery investigators. Our Mission Transposagen’s mission is to provide academic and drug discovery researchers with comprehensive gene editing products and services, empowering their efforts to discover the next generation of therapeutics. We accomplish this mission through internal innovation, in-licensing of cutting-edge technologies, and building lasting relationships with strategic partners. Our Clients Transposagen’s customers and partners include many of the top pharmaceutical and biotechnology companies in the world, as well as numerous academic laboratories and government agencies. Our team of experts understands the needs of biomedical researchers, working one-on-one with customers to provide the best models and reagents to fit their exact requirements.